Statement of GlaxoSmithKline on the Anti-counterfeit Drug Initiative of the Food and Drug Administration. November 3, 2003. Docket No. 2003N-0361. Available at: www.fda.gov.
2.
Salesman fell into a shadow market. Washington Post. October 19, 2003:A17-A17.
3.
Combating counterfeit drugs: a report of the Food and Drug Administration. February 18, 2004. Available at: http://www.fda.gov/o/initiatives/counterfeit/report02_04.html.
4.
Combating counterfeit drugs: a report of the Food and Drug Administration annual update. May 18, 2005. Available at: http://www.fda.gov/oc/initiatives/counterfeit/update2005.html.
5.
Healthcare Distribution Management Association. Recommended Guidelines for Pharmaceutical Distribution System Integrity. Available at: www.healthcaredistribution.org/gov_affairs/pdf_anti/Guidelines%20for%20Rx%20Distribution%20System%20Integroty%20Final%20Board%20Approved%2011-5-03.pdf.
